The effect of exogenous glucagon-like peptide-1 on the glycaemic response to small intestinal nutrient in the critically ill: a randomised double-blind placebo-controlled cross over study

被引:0
|
作者
Adam M Deane
Marianne J Chapman
Robert JL Fraser
Carly M Burgstad
Laura K Besanko
Michael Horowitz
机构
[1] University of Adelaide,, Discipline of Anaesthesia and Intensive Care
[2] Royal Adelaide Hospital,Department of Intensive Care
[3] Repatriation General Hospital,Investigation and Procedures Unit
[4] University of Adelaide,Discipline of Medicine
[5] Royal Adelaide Hospital,Department of Gastroenterology
来源
Critical Care | / 13卷
关键词
Glucagon; Enteral Feeding; Glucagon Concentration; Glycaemic Response; Royal Adelaide Hospital;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 50 条
  • [1] The effect of exogenous glucagon-like peptide-1 on the glycaemic response to small intestinal nutrient in the critically ill: a randomised double-blind placebo-controlled cross over study
    Deane, Adam M.
    Chapman, Marianne J.
    Fraser, Robert J. L.
    Burgstad, Carly M.
    Besanko, Laura K.
    Horowitz, Michael
    CRITICAL CARE, 2009, 13 (03)
  • [2] Effects of the glucagon-like peptide-1 receptor agonist dulaglutide on sexuality in healthy men: a randomised, double-blind, placebo-controlled crossover study
    Lengsfeld, Sophia
    Probst, Leila
    Emara, Yara
    Werlen, Laura
    Vogt, Deborah R.
    Bathelt, Cemile
    Baur, Fabienne
    Caviezel, Brida
    Vukajlovic, Tanja
    Fischer, Manuel
    Winzeler, Bettina
    EBIOMEDICINE, 2024, 107
  • [3] Exogenous glucagon-like peptide-1 attenuates the glycaemic response to postpyloric nutrient infusion in critically ill patients with type-2 diabetes
    Adam M Deane
    Matthew J Summers
    Antony V Zaknic
    Marianne J Chapman
    Robert JL Fraser
    Anna E Di Bartolomeo
    Judith M Wishart
    Michael Horowitz
    Critical Care, 15
  • [4] Exogenous glucagon-like peptide-1 attenuates the glycaemic response to postpyloric nutrient infusion in critically ill patients with type-2 diabetes
    Deane, Adam M.
    Summers, Matthew J.
    Zaknic, Antony V.
    Chapman, Marianne J.
    Fraser, Robert J. L.
    Di Bartolomeo, Anna E.
    Wishart, Judith M.
    Horowitz, Michael
    CRITICAL CARE, 2011, 15 (01):
  • [5] THE EFFECT OF THE GLUCAGON-LIKE PEPTIDE-1 RECEPTOR AGONIST LIRAGLUTIDE ON 24-H BLOOD PRESSURE VARIATION: A RANDOMIZED DOUBLE-BLIND PLACEBO-CONTROLLED CROSS OVER STUDY
    Kumarathurai, P.
    Anholm, C.
    Kristiansen, O. K.
    Nielsen, O. W.
    Haugaard, S. B.
    Sajadieh, A.
    JOURNAL OF HYPERTENSION, 2016, 34 : E42 - E43
  • [6] Impact of the timing of metformin administration on glycaemic and glucagon-like peptide-1 responses to intraduodenal glucose infusion in type 2 diabetes: a double-blind, randomised, placebo-controlled, crossover study
    Xie, Cong
    Iroga, Peter
    Bound, Michelle J.
    Grivell, Jacqueline
    Huang, Weikun
    Jones, Karen L.
    Horowitz, Michael
    Rayner, Christopher K.
    Wu, Tongzhi
    DIABETOLOGIA, 2024, 67 (07) : 1260 - 1270
  • [7] Effects of sucralose on insulin and glucagon-like peptide-1 secretion in healthy subjects: a randomized, double-blind, placebo-controlled trial
    Lertrit, Amornpan
    Srimachai, Sasinee
    Saetung, Sunee
    Chanprasertyothin, Suwannee
    Chailurkit, La-or
    Areevut, Chatvara
    Katekao, Pornalat
    Ongphiphadhanakul, Boonsong
    Sriphrapradang, Chutintorn
    NUTRITION, 2018, 55-56 : 125 - 130
  • [8] THE EFFECT OF EXOGENOUS GLUCAGON LIKE PEPTIDE-1 (GLP-1) ON SMALL INTESTINAL GLUCOSE MISORPTION UN THE CRITICALLY ILL
    Cousins, C. E.
    Miller, A.
    Plummer, M. P.
    Deane, A. M.
    Horowitz, M.
    Chapman, M. J.
    INTENSIVE CARE MEDICINE, 2014, 40 : S147 - S148
  • [9] EXOGENOUS GLUCAGON-LIKE PEPTIDE-1 ATTENUATES THE GLYCAEMIC RESPONSE TO ENTERAL NUTRIENT IN CRITICALLY ILL PATIENTS WITH PRE-EXISTING TYPE-2 DIABETES MELLITUS
    Deane, A.
    Chapman, M. J.
    Fraser, R. J.
    Summers, M. J.
    Zaknic, A. V.
    DiBartolomeo, A.
    Horowitz, M.
    INTENSIVE CARE MEDICINE, 2010, 36 : S172 - S172
  • [10] Effect of exercise combined with glucagon-like peptide-1 receptor agonist treatment on cardiac function: A randomized double-blind placebo-controlled clinical trial
    Jorgensen, Peter G.
    Jensen, Magnus T.
    Mensberg, Pernille
    Storgaard, Heidi
    Nyby, Signe
    Jensen, Jan S.
    Knop, Filip K.
    Vilsboll, Tina
    DIABETES OBESITY & METABOLISM, 2017, 19 (07): : 1040 - 1044